Asthma Trial, Recruiting NCT07224061 Sponsor: Montefiore Medical Center Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT07224061
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Your child has been diagnosed with asthma by a doctor, and this is recorded in their medical records.
  • Your child has persistent or poorly controlled asthma, meaning at least one of the following applies in the past month: symptoms on more than 2 days per week, using a quick-relief inhaler more than 2 days per week, nighttime symptoms more than 2 nights per month, or needing oral steroids (like prednisone) more than twice in the past year.
  • Your child is between 4 and 12 years old and attends a public, charter, or private school in New York City (mainly the Bronx) or in the lower Hudson Valley area (Eastchester, Westchester, Rockland, or Yonkers).
  • The parent or caregiver is able to speak and understand English or Spanish (reading is not required, as research staff will read surveys aloud if needed).
  • The parent or legal guardian is able to give permission for the child to join, and children aged 7 and older must also agree to participate.
  • Your household has access to a phone for surveys, and a smartphone, iPad, or computer to complete and sign forms electronically.

Who may not be able to join:

  • Your family is planning to move away from the school or city within the next 6 months.
  • Your child has other significant health conditions, such as a serious heart condition from birth, cystic fibrosis, or another long-term lung disease.
  • Your child is in foster care or another situation where a legal guardian is not available to give consent.
  • Your child is currently taking part in another asthma-related research study.
  • Your child has a severe developmental condition (for example, severe autism) that would make it too difficult to complete questionnaires about asthma control.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marina Reznik, MD, MS, Montefiore Medical Center

Phone: 718-741-2494

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Montefiore Medical Center
Registry
ClinicalTrials.gov
Start date
12 February 2026
Est. completion
30 June 2031

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Asthma Control - continuous

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov